S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case

WBB Securities Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at WBB Securities. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by WBB Securities.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
$0.71
9/22/2021Upgraded byWBB Securities-Buy -> Strong-Buy$6.25HighView details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 9/22/2021
Omeros Co. stock logo
OMER
Omeros
$4.78
+6.2%
6/18/2021Target Raised byWBB Securities-Strong-Buy$75.00 -> $100.00MediumView details for WBB Securities rating of Omeros (NASDAQ:OMER) on 6/18/2021
RedHill Biopharma Ltd. stock logo
RDHL
RedHill Biopharma
$0.57
-8.1%
5/28/2021Downgraded byWBB Securities-Strong-Buy -> Buy$680.00 -> $640.00HighView details for WBB Securities rating of RedHill Biopharma (NASDAQ:RDHL) on 5/28/2021
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
$39.73
+2.5%
6/9/2020Downgraded byWBB Securities-Buy -> Hold$31.00LowView details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/9/2020
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
$0.71
12/4/2019Upgraded byWBB Securities-Speculative Buy -> Buy$6.25MediumView details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 12/4/2019
RedHill Biopharma Ltd. stock logo
RDHL
RedHill Biopharma
$0.57
-8.1%
7/12/2019Upgraded byWBB Securities-Buy -> Strong-Buy$680.00HighView details for WBB Securities rating of RedHill Biopharma (NASDAQ:RDHL) on 7/12/2019
ADMA Biologics, Inc. stock logo
ADMA
ADMA Biologics
$5.52
+3.0%
4/4/2019Upgraded byWBB Securities-BuyLowView details for WBB Securities rating of ADMA Biologics (NASDAQ:ADMA) on 4/4/2019
Marker Therapeutics, Inc. stock logo
MRKR
Marker Therapeutics
$3.69
+1.7%
3/29/2019Upgraded byWBB Securities-Buy -> Strong-Buy$7.29HighView details for WBB Securities rating of Marker Therapeutics (NASDAQ:MRKR) on 3/29/2019
RedHill Biopharma Ltd. stock logo
RDHL
RedHill Biopharma
$0.57
-8.1%
3/12/2019Upgraded byWBB Securities-Speculative Buy -> Buy$680.00HighView details for WBB Securities rating of RedHill Biopharma (NASDAQ:RDHL) on 3/12/2019
RedHill Biopharma Ltd. stock logo
RDHL
RedHill Biopharma
$0.57
-8.1%
12/31/2018Initiated byWBB Securities-Buy$214.40MediumView details for WBB Securities rating of RedHill Biopharma (NASDAQ:RDHL) on 12/31/2018
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
$39.73
+2.5%
9/20/2018Upgraded byWBB Securities-Buy -> Strong-BuyLowView details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 9/20/2018
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
6/20/2018Reiterated byWBB Securities-BuyLowView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 6/20/2018
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
$39.73
+2.5%
6/11/2018Upgraded byWBB Securities-Hold -> BuyMediumView details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/11/2018
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
$0.71
5/23/2018Upgraded byWBB Securities-Hold -> BuyMediumView details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 5/23/2018
Omeros Co. stock logo
OMER
Omeros
$4.78
+6.2%
3/26/2018Reiterated byWBB Securities-Buy$75.00HighView details for WBB Securities rating of Omeros (NASDAQ:OMER) on 3/26/2018
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
$51.88
+7.9%
12/6/2017Reiterated byWBB Securities-Buy$150.00LowView details for WBB Securities rating of Celldex Therapeutics (NASDAQ:CLDX) on 12/6/2017
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
$39.73
+2.5%
10/9/2017Upgraded byWBB Securities-Hold -> Buy$2.00N/AView details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 10/9/2017
LivaNova PLC stock logo
LIVN
LivaNova
$55.24
+0.8%
8/15/2017Downgraded byWBB Securities-Hold -> Sell$50.00LowView details for WBB Securities rating of LivaNova (NASDAQ:LIVN) on 8/15/2017
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
$0.71
8/11/2017Upgraded byWBB Securities-Sell -> HoldLowView details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 8/11/2017
Omeros Co. stock logo
OMER
Omeros
$4.78
+6.2%
6/14/2017Reiterated byWBB Securities-Strong-Buy$75.00HighView details for WBB Securities rating of Omeros (NASDAQ:OMER) on 6/14/2017
Omeros Co. stock logo
OMER
Omeros
$4.78
+6.2%
3/30/2017Reiterated byWBB Securities-Buy$75.00MediumView details for WBB Securities rating of Omeros (NASDAQ:OMER) on 3/30/2017
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
$0.71
2/22/2017Upgraded byWBB Securities-Sell -> Hold$7.25N/AView details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 2/22/2017
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$5.28
+4.8%
2/5/2017Reiterated byWBB Securities-Buy$60,000.00N/AView details for WBB Securities rating of T2 Biosystems (NASDAQ:TTOO) on 2/5/2017
Omeros Co. stock logo
OMER
Omeros
$4.78
+6.2%
11/17/2016Reiterated byWBB SecuritiesAnalyst Stephen BrozakBuy$75.00N/AView details for WBB Securities rating of Omeros (NASDAQ:OMER) on 11/17/2016
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
$39.73
+2.5%
11/2/2016Upgraded byWBB Securities-Sell -> Hold$4.00 -> $1.90N/AView details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 11/2/2016
Omeros Co. stock logo
OMER
Omeros
$4.78
+6.2%
10/17/2016Reiterated byWBB SecuritiesAnalyst Stephen BrozakBuy$75.00N/AView details for WBB Securities rating of Omeros (NASDAQ:OMER) on 10/17/2016
SCYNEXIS, Inc. stock logo
SCYX
SCYNEXIS
$1.62
10/7/2016Upgraded byWBB Securities-Buy -> Strong-Buy$80.00N/AView details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 10/7/2016
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
$0.71
9/23/2016Downgraded byWBB Securities-Hold -> Sell$10.50N/AView details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 9/23/2016
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
9/20/2016Reiterated byWBB SecuritiesAnalyst Stephen BrozakStrong-Buy$40.00 -> $60.00N/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 9/20/2016
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
$39.73
+2.5%
9/12/2016Downgraded byWBB Securities-Hold -> Sell$5.00 -> $4.00N/AView details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 9/12/2016
LivaNova PLC stock logo
LIVN
LivaNova
$55.24
+0.8%
8/31/2016Reiterated byWBB Securities-Hold$60.00N/AView details for WBB Securities rating of LivaNova (NASDAQ:LIVN) on 8/31/2016
SCYNEXIS, Inc. stock logo
SCYX
SCYNEXIS
$1.62
8/9/2016Upgraded byWBB Securities-Speculative Buy -> Buy$80.00N/AView details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 8/9/2016
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$5.28
+4.8%
7/20/2016Upgraded byWBB SecuritiesAnalyst Stephen BrozakBuy -> Strong-Buy$55,000.00 -> $60,000.00N/AView details for WBB Securities rating of T2 Biosystems (NASDAQ:TTOO) on 7/20/2016
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$5.28
+4.8%
7/8/2016Reiterated byWBB SecuritiesAnalyst Stephen BrozakBuy$55,000.00N/AView details for WBB Securities rating of T2 Biosystems (NASDAQ:TTOO) on 7/8/2016
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$5.28
+4.8%
6/22/2016Upgraded byWBB SecuritiesAnalyst Stephen BrozakSpeculative Buy -> Buy$55,000.00N/AView details for WBB Securities rating of T2 Biosystems (NASDAQ:TTOO) on 6/22/2016
Omeros Co. stock logo
OMER
Omeros
$4.78
+6.2%
6/14/2016Reiterated byWBB Securities-Buy$75.00N/AView details for WBB Securities rating of Omeros (NASDAQ:OMER) on 6/14/2016
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
6/8/2016Reiterated byWBB SecuritiesAnalyst Stephen BrozakBuy$40.00N/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 6/8/2016
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
5/2/2016Reiterated byWBB SecuritiesAnalyst Stephen BrozakStrong-Buy$40.00N/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/2/2016
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
4/26/2016Reiterated byWBB SecuritiesAnalyst Stephen BrozakBuy$40.00N/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 4/26/2016
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
3/30/2016Reiterated byWBB SecuritiesAnalyst Stephen BrozakBuy$40.00N/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 3/30/2016
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$5.28
+4.8%
2/17/2016Initiated byWBB Securities-Speculative Buy$55,000.00N/AView details for WBB Securities rating of T2 Biosystems (NASDAQ:TTOO) on 2/17/2016
Travelzoo stock logo
TZOO
Travelzoo
$8.97
-5.1%
2/17/2016Initiated byWBB Securities-Speculative Buy$11.00N/AView details for WBB Securities rating of Travelzoo (NASDAQ:TZOO) on 2/17/2016
SCYNEXIS, Inc. stock logo
SCYX
SCYNEXIS
$1.62
1/4/2016Initiated byWBB SecuritiesAnalyst Stephen BrozakBuy$80.00N/AView details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 1/4/2016
SCYNEXIS, Inc. stock logo
SCYX
SCYNEXIS
$1.62
12/29/2015Initiated byWBB Securities-Buy$80.00N/AView details for WBB Securities rating of SCYNEXIS (NASDAQ:SCYX) on 12/29/2015
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
11/22/2015Reiterated byWBB SecuritiesAnalyst Stephen BrozakBuy$40.00N/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/22/2015
Cytosorbents Co. stock logo
CTSO
Cytosorbents
$0.95
-1.0%
10/29/2015Upgraded byWBB Securities-Speculative Buy -> Buy$13.00N/AView details for WBB Securities rating of Cytosorbents (NASDAQ:CTSO) on 10/29/2015
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
$0.71
10/9/2015Upgraded byWBB Securities-Sell -> Hold$13.00N/AView details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 10/9/2015
Omeros Co. stock logo
OMER
Omeros
$4.78
+6.2%
8/18/2015Target Raised byWBB Securities-Strong-Buy$60.00 -> $75.00N/AView details for WBB Securities rating of Omeros (NASDAQ:OMER) on 8/18/2015
Omeros Co. stock logo
OMER
Omeros
$4.78
+6.2%
8/18/2015Reiterated byWBB Securities-Buy$60.00N/AView details for WBB Securities rating of Omeros (NASDAQ:OMER) on 8/18/2015
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
8/13/2015Reiterated byWBB SecuritiesAnalyst Stephen BrozakBuy$35.00 -> $40.00N/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 8/13/2015
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
$39.73
+2.5%
8/9/2015Reiterated byWBB Securities-Hold$5.00N/AView details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 8/9/2015
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
$39.73
+2.5%
6/24/2015Downgraded byWBB Securities-Speculative Buy -> Hold$5.00N/AView details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/24/2015
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
$51.88
+7.9%
6/1/2015Reiterated byWBB SecuritiesAnalyst Stephen BrozakBuy$450.00 -> $600.00N/AView details for WBB Securities rating of Celldex Therapeutics (NASDAQ:CLDX) on 6/1/2015
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
5/22/2015Reiterated byWBB SecuritiesAnalyst Stephen BrozakStrong-Buy$25.00 -> $35.00N/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/22/2015
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
$0.71
4/23/2015Initiated byWBB Securities-Sell$13.00N/AView details for WBB Securities rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/23/2015
Cytosorbents Co. stock logo
CTSO
Cytosorbents
$0.95
-1.0%
2/25/2015Initiated byWBB Securities-Speculative Buy$13.00N/AView details for WBB Securities rating of Cytosorbents (NASDAQ:CTSO) on 2/25/2015
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
1/15/2015Reiterated byWBB SecuritiesAnalyst Stephen BrozakBuyN/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 1/15/2015
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
11/26/2014Upgraded byWBB SecuritiesAnalyst Stephen BrozakBuy -> Strong-Buy$25.00N/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/26/2014
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
7/29/2014Upgraded byWBB SecuritiesAnalyst Stephen BrozakSpeculative Buy -> BuyN/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 7/29/2014
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
7/29/2014Target Raised byWBB SecuritiesAnalyst Stephen BrozakSpeculative Buy -> Buy$25.00N/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 7/29/2014
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
$39.73
+2.5%
6/26/2014Initiated byWBB Securities-Hold$18.00N/AView details for WBB Securities rating of Arcturus Therapeutics (NASDAQ:ARCT) on 6/26/2014
Omeros Co. stock logo
OMER
Omeros
$4.78
+6.2%
4/7/2014Target Raised byWBB Securities-Strong-Buy$20.00 -> $30.00N/AView details for WBB Securities rating of Omeros (NASDAQ:OMER) on 4/7/2014
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
11/26/2013Upgraded byWBB Securities-Sell -> Speculative Buy$9.00 -> $19.00N/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/26/2013
UiPath Inc. stock logo
PATH
UiPath
$23.63
-0.5%
1/22/2013Upgraded byWBB Securities-Buy -> Strong-Buy$7.00N/AView details for WBB Securities rating of UiPath (NYSE:PATH) on 1/22/2013
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
$0.50
9/24/2012Upgraded byWBB Securities-Hold -> Speculative Buy$20.00 -> $40.00N/AView details for WBB Securities rating of STRATA Skin Sciences (NASDAQ:SSKN) on 9/24/2012
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
9/12/2012Downgraded byWBB Securities-Hold -> Sell$8.00 -> $9.00N/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 9/12/2012
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
$5.62
-0.2%
8/14/2012Downgraded byWBB Securities-Buy -> Hold$8.50 -> $4.40N/AView details for WBB Securities rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 8/14/2012
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
8/9/2012Initiated byWBB Securities-Buy -> Hold$8.00N/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 8/9/2012
Vericel Co. stock logo
VCEL
Vericel
$44.71
-2.1%
7/24/2012Upgraded byWBB Securities-Buy -> Strong-Buy$3.00 -> $3.00N/AView details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 7/24/2012
Vericel Co. stock logo
VCEL
Vericel
$44.71
-2.1%
6/4/2012Upgraded byWBB Securities-Speculative Buy -> Buy$3.00N/AView details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 6/4/2012
Vericel Co. stock logo
VCEL
Vericel
$44.71
-2.1%
4/16/2012Upgraded byWBB Securities-Hold -> Speculative Buy$2.50 -> $3.00N/AView details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 4/16/2012
Omeros Co. stock logo
OMER
Omeros
$4.78
+6.2%
3/22/2012Target Raised byWBB Securities-Strong-Buy$10.50 -> $20.00N/AView details for WBB Securities rating of Omeros (NASDAQ:OMER) on 3/22/2012
Jazz Pharmaceuticals plc stock logo
JAZZ
Jazz Pharmaceuticals
$118.85
0.0%
12/8/2011Downgraded byWBB Securities-Buy -> Hold$15.00 -> $40.00N/AView details for WBB Securities rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 12/8/2011
Vericel Co. stock logo
VCEL
Vericel
$44.71
-2.1%
12/6/2011Upgraded byWBB Securities-Sell -> Hold$2.00 -> $2.50N/AView details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 12/6/2011
Geron Co. stock logo
GERN
Geron
$2.26
+13.0%
11/16/2011Downgraded byWBB Securities-Strong Buy -> Buy$19.00 -> $6.00N/AView details for WBB Securities rating of Geron (NASDAQ:GERN) on 11/16/2011
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$1.30
+1.6%
7/7/2011Initiated byWBB Securities-Sell$36.00N/AView details for WBB Securities rating of Microbot Medical (NASDAQ:MBOT) on 7/7/2011
Emergent BioSolutions Inc. stock logo
EBS
Emergent BioSolutions
$3.39
+5.0%
5/31/2011Target Raised byWBB Securities-Strong Buy$20.50 -> $30.00N/AView details for WBB Securities rating of Emergent BioSolutions (NYSE:EBS) on 5/31/2011
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$1.62
-0.6%
3/17/2011Downgraded byWBB Securities-Strong-Buy -> Buy$100.00N/AView details for WBB Securities rating of Protalix BioTherapeutics (NYSE:PLX) on 3/17/2011
Vericel Co. stock logo
VCEL
Vericel
$44.71
-2.1%
2/9/2011Initiated byWBB Securities-Sell$2.00N/AView details for WBB Securities rating of Vericel (NASDAQ:VCEL) on 2/9/2011
Osiris Therapeutics, Inc. stock logo
OSIR
Osiris Therapeutics
$18.99
1/31/2011Downgraded byWBB Securities-Sell -> Sell Short$5.00 -> $5.00N/AView details for WBB Securities rating of Osiris Therapeutics (OTCMKTS:OSIR) on 1/31/2011
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$128.67
+0.6%
12/29/2010Initiated byWBB Securities-Speculative Buy$3.00N/AView details for WBB Securities rating of Sarepta Therapeutics (NASDAQ:SRPT) on 12/29/2010

MarketBeat Community Rating for WBB Securities

Community Ranking:  2.7 out of 5 (
2.7 of 5 stars)
Outperform Votes:  23,190 (Vote Outperform)
Underperform Votes:  19,886 (Vote Underperform)
Total Votes:  43,076
MarketBeat's community ratings are surveys of what our community members think about WBB Securities and other research firms. Vote "Outperform" if you believe WBB Securities's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WBB Securities's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools